10th Annual Drug Discovery Leaders Summit 15th & 16th June 2009
Monday 15th June 2009, Fairmont le Montreux Palace, Montreux, Switzerland
Over 2 days, the comprehensive and scientific conference programme will feature key note addresses, case study presentations, panel and roundtable discussions of over 45 senior level industry speakers from leading pharmaceutical, biotechnology organisations as well as academia covering the following hot topics:
R&D STRATEGIES –Strategies to enhance drug discovery, overcoming attrition, prediction tools that drive clear decision rules, risk management
DRUG DESIGN & TARGETS – GPCR’s, RNAi, and Protein Kinases, reducing risk of toxicity, structure based discovery, hit to lead strategies, fragment based techniques
SCREENING TECHNIQUES & ASSAY DEVELOPMENT – Improving quality of assays, cost effective HTS & HCS, moving towards more complex systems
PHARMA/BIOTECH ALLIANCES COLLABORATIONS & OUTSOURCING –,Successful partnerships, managing alliances, balancing conflicting interests, biotech technology platforms
BIOMARKERS & TRANSLATIONAL MEDICINE –Personalised medicine, decision making tools, surrogate endpoints, translational strategies, validation, biobanking
IN SILICO APPROACHES TO SOLVE DRUG DISCOVERY – In-silico data, data mining, predictive modelling, systems biology
2009 Advisory Panel Includes:
Gerhard Mueller, Chief Scientific Officer and Managing Director, Proteros
Bahija Jallal, Vice President, Translational Sciences, MedImmune
Samantha O’Connor, Director, Worldwide Business Development, Pfizer
Martin Klumpp, Lab Head Assay Development and Screening, Novartis
Emilo Diez, Site Director, Molecular Discovery Research, GlaxoSmithKline
Anthony Davies, HCA Research Facility Manager, Trinity College Dublin
Tim Hammonds, Head of Biochemistry and HTS, Cancer Research Technology
Taoufik Ouatas, Senior Scientist, Exploratory Development Department, Astellas Pharma Europe B.V
Read More...
|